{
  "num_tested_probands": [
    1,
    1,
    0,
    0
  ],
  "num_positive_het_probands": [
    0,
    0,
    0,
    0
  ],
  "positive_phenotypes": [
    "Levodopa-responsive Parkinsonism",
    [
      "Infantile-onset leukoencephalopathy",
      "Infantile-onset Parkinsonism"
    ],
    [],
    []
  ],
  "num_compound_or_double_hets": [
    1,
    1,
    0
  ],
  "explanation": {
    "num_tested_probands": [
      "The patient is the only proband mentioned in the report.",
      "The patient was the first and only child born to non-consanguineous parents, indicating that there is only one proband tested.",
      "The study tested a single patient, not multiple probands.",
      "No probands were tested in this article."
    ],
    "num_positive_het_probands": [
      "There is no mention of a heterozygous carrier among the probands.",
      "There is no mention of a single heterozygous carrier in the report.",
      "There is no mention of heterozygous carriers in the report.",
      "No heterozygous carriers were reported in this article."
    ],
    "positive_phenotypes": [
      "The phenotype 'Levodopa-responsive Parkinsonism' is explicitly stated as the clinical hallmark of the disease.",
      "The title of the paper mentions 'Multiple Congenital Anomalies-Hypotonia-Seizures Syndrome', which is a shared phenotype among patients with biallelic mutations in WARS2. The patient's clinical presentation matches this syndrome.",
      "The shared phenotype mentioned in the title and discussion section is 'Levodopa-responsive Parkinsonism'.",
      "The phenotype 'Levodopa-responsive infantile-onset Parkinsonism' was mentioned, but no specific clinical phenotypes were described for individual probands."
    ],
    "num_compound_or_double_hets": [
      "The patient has compound heterozygous mutations in WARS2, which is mentioned in the report.",
      "The patient was compound heterozygous for two variants in the WARS2 gene, indicating that there is one individual reported to have compound or double heterozygous mutations.",
      "The patient has compound heterozygous mutations in WARS2, but this information refers to a different aspect of the study.",
      "No compound or double heterozygotes were reported in this article."
    ]
  }
}